Skip to content
Home/Companies/Biotech/Phaeosynt GmbH
PG

Phaeosynt GmbH

Biotech·Germany·Active·1yr hold

Phaeosynt GmbH is a biotech company, headquartered in Germany.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Phaeosynt GmbH?

Phaeosynt GmbH is currently owned by NBank Capital through NBank Capital Beteiligungsfonds (2009 vintage), since 2025.

Hand-verified · updated 2026-07-07

NBank Capital
Investor
NBank Capital
NBank Capital Beteiligungsfonds · 2009 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from NBank Capital Beteiligungsfonds

Other portfolio companies in the same fund.

BIOWEG GmbH
Active
ClimateTechGermany· 2025
Skyseed GmbH
Active
ClimateTechGermany· 2025
Allogenetics GmbH
Active
BiotechGermany· 2024
Sascotec Horsepower GmbH
Active
IndustrialsGermany· 2024
NEXSD Automotive Innovations GmbH
Active
MobilityGermany· 2023
Sustainable Manufacturing GmbH (Recozy)
Active
ConsumerGermany· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings